Hyperoxemia may be more beneficial for patients with sepsis

Abstract

To the Editor, We have read with great interest the clinical study by Dong-gon et al. published in Critical Care [1]. The study showed a robust correlation between higher PaO2 (≥ 80 mmHg) during the first three ICU days and a lower 28-day mortality. The optimal PaO2 range represents an intriguing and significant subject for exploration. Our department is the general Intensive Care Unit (ICU) of a tertiary teaching hospital, with sepsis-related patients making up approximately one-fourth to one-third of the total patient population. We are deeply interested in exploring the issue of "optimal oxygenation". Therefore, we conducted a statistical analysis of patients admitted to our department with sepsis. We retrospectively examined adult patients who admitted to ICU with sepsis as the primary diagnosis. Data were collected from consecutive electronic health records of Affiliated Hospital of Chengdu University between January 2021 and December 2023. The inclusion criteria were as follows: (1) aged ≥ 18 years; (2) The primary diagnosis was related to sepsis; (3) the length of ICU stay ≥ 3 days. The exclusion criteria included a lack of data on PaO2 during the first three days of ICU admission due to missing information, less than three days of ICU stay, or readmission or the presence of severe concurrent organ failures (e.g., myocardial infarction, uremia, advanced malignant tumor). We also defined ICU day 1 as the time from ICU admission to the first midnight, ICU day 2 as the next 24 h from the first midnight, and ICU day 3 as the time from the second midnight to the third midnight. The values of PaO2 over the first three days of ICU admission were collected. When multiple arterial blood gas analysis was performed, the lowest result regarding PaO2 was recorded. Based on the PaO2 value from arterial blood gas analysis, patients who maintained a PaO2 ≥ 80 mmHg during the first three days in the ICU were assigned to the liberal PaO2 group, while the remaining were included in the conservative PaO2 group. We used univariate logistic regression analysis to examine the association between the PaO2 and the clinical outcomes (ICU mortality, in-hospital mortality and invasive ventilation). This analysis provided odds ratios and 95% CIs. Two-sided P values < 0.05 were considered significant. All analysis were performed using SPSS Statistics for Windows, version 24.0. During the study period, 489 adult patients admitted to the ICU were screened, after 197 patients were excluded from the analysis (94 patients had an ICU stay of less than 3 days, 10 patients were readmitted, 93 patients had severe concurrent organ failures), ultimately 292 patients were included in the final analysis (Fig. 1). Fig. 1 Flow chart The total in-hospital mortality rate and ICU mortality for our study population were 35.3% (n = 103) and 32.5% (n = 95). In-hospital mortality and ICU mortality were significantly different between the conservative PaO2 group and the liberal PaO2 group. The liberal PaO2 group showed a significantly higher probability of survival (OR 0.53, 95% CI 0.32–0.88, for in-hospital mortality; OR 0.49, 95% CI 0.29–0.83, for ICU mortality). There was no statistical difference in invasive ventilation between the two groups (Table 1). Table 1 Comparing outcomes between conservative PaO2 and liberal PaO2 for sepsis patients Outcomes Conservative PaO2 Liberal PaO2 OR 95% CI p-value ICU mortality, n (%) 66/170 (38.8) 29/122 (23.8) 0.49 0.29–0.83 0.007 Hospital mortality, n (%) 70/170 (41.2) 33/122 (27.0) 0.53 0.32–0.88 0.013 Invasive ventilation, n (%) 118/170 (69.4) 75/122 (61.5) 0.70 0.43–1.15 0.158 Our findings are consistent with Dong-gon’s [1], indicating that real-world data can support the results of their results. This finding is of great significance. Sepsis is at a high risk of morbidity and mortality, imposing a significant global economic burden. Currently, in line with various guidelines and those specific to COVID-19 [2, 3], it is recommended to maintain SpO2 levels below 100%. This is because exposure to hyperoxemia may cause oxidative damage, inflammation, and increase alveolar-capillary permeability [4–8]. The results of this study are poised to shift the perspectives of ICU doctors, benefiting a larger population of sepsis patients. Certainly, obtaining more reliable results requires high-quality randomized controlled trials (RCTs) for confirmation. It is acknowledged that patients in extremely critical conditions may not reach a PaO2 level of at least 80 mmHg, resulting in increased mortality rates. Further research is essential to mitigate the influence of this scenario. Moreover, additional studies are needed to establish the optimal cutoff value for liberty PaO2 and to address inquiries concerning the duration of maintaining elevated PaO2 levels, all of which warrant further investigation. In summary, according to the study’s data and our findings, we suggest, that sepsis patients was given higher PaO2(PaO2 ≥ 80 mmHg) for the first 3 ICU days. Overall oxygenation target for sepsis patients should be subject to further investigations.